JW Pharmaceutical Corporation

001060.KS·KSE·Healthcare
Compare
23,350.00+250.00 (+1.08%)today
At close: Nov 5, 3:30 PM KST · May be delayed up to 20 min · KRW

Prices may be delayed up to 20 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close23,100.00
Open23,350.00
Day range23,100.0023,900.00
52-week range21,550.0039,250.00
Off day high−2.30%
Off 52-week high−40.51%
Volume53.86K
Avg. volume (3M)57.43K
Market cap531.36B
EPS (TTM)—
Forward P/E—
P/E ratio (TTM)—
Dividend yield2.81% (650.00)
Beta (5Y)1.05
Shares outstanding22.55M
Short interest—
Earnings dateJul 30, 2025 (est.)
Analyst target—
Profit margin12.34%

Against its peers

Compare in full ›
001060.KS 016580.KS 003000.KS 067080.KQ 000020.KS 001360.KS
Market cap 531.36B 200.18B 380.35B 169.30B 143.86B 118.87B
P/E (TTM) — — — — — —
Forward P/E — — — — — —
Price/book — — — — — —
Dividend yield 2.81% 2.76% 1.95% 1.63% 1.25% —
1-year change −4.35% −5.81% +1.19% −45.27% −16.64% −16.75%
Today +1.08% −0.28% +0.39% −0.11% −0.38% +0.08%

The closest companies by business and industry (Drug Manufacturers - Specialty & Generic). Prices may be delayed up to 20 min.

Seoul Economic Daily·Negative

JW Pharmaceutical Q3 Revenue Rises 6.3%, Profit Falls 10.7%

Korea's first economic newspaper, established in 1960. Providing comprehensive coverage of Korean business, finance, technology, and economic news. JW Pharmaceutical (001060.KS) posted a 6.3% rise in third-quarter revenue from a year…

From the 4Search news index, newest first.

In the news

3mentions in 30 days
3with it in the headline
Positivesentiment

Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 3 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4SEARCH.business index. Terms of use. How to use Finance